Tianjin Chase Sun Pharmaceutical Co Ltd (300026) — Capital Reinvestment Ratio
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥153.30 Million) in capital expenditures (CN¥21.58 Million). See net asset quality index of Tianjin Chase Sun Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Chase Sun Pharmaceutical Co Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Tianjin Chase Sun Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Check total reinvestment intensity of Tianjin Chase Sun Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. For live market cap and broader valuation context, see market value of Tianjin Chase Sun Pharmaceutical Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥852.24 Million | CN¥193.12 Million | ▼ -0.1% |
| 2023 | 0.23x | CN¥1.53 Billion | CN¥347.12 Million | ▼ -78.0% |
| 2022 | 1.03x | CN¥745.35 Million | CN¥770.27 Million | ▼ -40.3% |
| 2021 | 1.73x | CN¥391.60 Million | CN¥677.45 Million | ▼ -39.7% |
| 2020 | 2.87x | CN¥196.66 Million | CN¥563.78 Million | ▲ +4.8% |
| 2019 | 2.73x | CN¥216.10 Million | CN¥591.01 Million | ▲ +260.0% |
| 2018 | 0.76x | CN¥388.19 Million | CN¥294.89 Million | ▲ +47.1% |
| 2017 | 0.52x | CN¥742.38 Million | CN¥383.34 Million | ▼ -44.3% |
| 2016 | 0.93x | CN¥448.08 Million | CN¥415.52 Million | ▼ -49.8% |
| 2015 | 1.85x | CN¥121.00 Million | CN¥223.35 Million | ▲ +55.2% |
| 2014 | 1.19x | CN¥149.94 Million | CN¥178.37 Million | ▲ +59.4% |
| 2013 | 0.75x | CN¥143.60 Million | CN¥107.20 Million | ▼ -48.6% |
| 2012 | 1.45x | CN¥152.21 Million | CN¥221.17 Million | ▼ -80.3% |
| 2011 | 7.37x | CN¥35.64 Million | CN¥262.51 Million | ▲ +201.7% |
| 2010 | 2.44x | CN¥46.25 Million | CN¥112.90 Million | ▲ +561.8% |
| 2009 | 0.37x | CN¥135.06 Million | CN¥49.82 Million | ▼ -40.6% |
| 2008 | 0.62x | CN¥77.74 Million | CN¥48.28 Million | ▲ +661.3% |
| 2007 | 0.08x | CN¥72.01 Million | CN¥5.87 Million | ▼ -96.8% |
| 2006 | 2.54x | CN¥1.22 Million | CN¥3.12 Million | — |